MEDLIVE (02192) announced its results for the six months ended June 30, 2025. The group achieved revenue of 312 million yuan during the period, representing a year-over-year increase of 28.2%. Profit attributable to owners of the parent company reached 155 million yuan, up 5.9% compared to the same period last year. Basic earnings per share were 21.2 cents.